Shares of Novavax, Inc. (NVAX Quick QuoteNVAX ) have skyrocketed 117.2% this year so far compared with the industry’s 0.8% rise.
Image Source: Zacks Investment Research
This rally in share price is primarily being driven by the company’s potential COVID-19 vaccine candidate NVX-CoV2373. The COVID vaccine was found to be effective against strains of the coronavirus first found in the United Kingdom, the United States, Brazil, South Africa and India.
COVID-19 Vaccine
The vaccine is developed using Novavax’s proprietary nanoparticle....More>>>